Terms: = Breast cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Diagnosis
13 results:
1. High-Grade Spindle Cell Lesions of the breast: Key Pathologic and Clinical Updates.
Yoon E; Ding Q; Hunt K; Sahin A
Surg Pathol Clin; 2022 Mar; 15(1):77-93. PubMed ID: 35236635
[TBL] [Abstract] [Full Text] [Related]
2. Rank-preserving biclustering algorithm: a case study on miRNA breast cancer.
Mandal K; Sarmah R; Bhattacharyya DK; Kalita JK; Borah B
Med Biol Eng Comput; 2021 Apr; 59(4):989-1004. PubMed ID: 33840048
[TBL] [Abstract] [Full Text] [Related]
3. Rest-activity rhythm in breast cancer survivors: an update based on non-parametric indices.
Galasso L; Montaruli A; Mulè A; Castelli L; Bruno E; Pasanisi P; Caumo A; Esposito F; Roveda E
Chronobiol Int; 2020 Jun; 37(6):946-951. PubMed ID: 32326769
[TBL] [Abstract] [Full Text] [Related]
4.
Chang HY; Koh VCY; Md Nasir ND; Ng CCY; Guan P; Thike AA; Teh BT; Tan PH
J Clin Pathol; 2020 Jan; 73(1):51-56. PubMed ID: 31662438
[TBL] [Abstract] [Full Text] [Related]
5. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract] [Full Text] [Related]
6. Rest-activity circadian rhythm in breast cancer survivors at 5 years after the primary diagnosis.
Roveda E; Bruno E; Galasso L; Mulè A; Castelli L; Villarini A; Caumo A; Esposito F; Montaruli A; Pasanisi P
Chronobiol Int; 2019 Aug; 36(8):1156-1165. PubMed ID: 31177874
[TBL] [Abstract] [Full Text] [Related]
7. breast cancer treatment in high-risk elderly patients: A challenging situation and difficult decisions.
Bano R; Khan AI; Zafar W; Zaidi AA; Zaidi AA; Chaudhry MZ; Khan HM
J Pak Med Assoc; 2016 Oct; 66(10):1267-1271. PubMed ID: 27686301
[TBL] [Abstract] [Full Text] [Related]
8. Steroid receptor RNA activator: Biologic function and role in disease.
Liu C; Wu HT; Zhu N; Shi YN; Liu Z; Ao BX; Liao DF; Zheng XL; Qin L
Clin Chim Acta; 2016 Aug; 459():137-146. PubMed ID: 27282881
[TBL] [Abstract] [Full Text] [Related]
9. Current trends in oxysterol research.
Griffiths WJ; Abdel-Khalik J; Hearn T; Yutuc E; Morgan AH; Wang Y
Biochem Soc Trans; 2016 Apr; 44(2):652-8. PubMed ID: 27068984
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women.
Kim JH; Shin MH; Kweon SS; Park MH; Yoon JH; Lee JS; Choi C; Fackler MJ; Sukumar S
Gynecol Oncol; 2010 Aug; 118(2):176-81. PubMed ID: 20466412
[TBL] [Abstract] [Full Text] [Related]
11. Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis.
Lee JS; Fackler MJ; Teo WW; Lee JH; Choi C; Park MH; Yoon JH; Zhang Z; Argani P; Sukumar S
Cancer Biol Ther; 2008 Sep; 7(9):1398-406. PubMed ID: 18769130
[TBL] [Abstract] [Full Text] [Related]
12. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract] [Full Text] [Related]
13. Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells.
Tanosaki S; Ikezoe T; Heaney A; Said JW; Dan K; Akashi M; Koeffler HP
Breast Cancer Res Treat; 2003 Jun; 79(3):335-45. PubMed ID: 12846418
[TBL] [Abstract] [Full Text] [Related]
